Aegon N.V. Executive Board Remuneration Policy 2020
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NP Key Contacts.Pdf
IGP Network Partners: Key Contacts Region: Americas Country / Territory IGP Network Partner IGP Contact Email Type IGP Regional Coordinator Mr. Michael Spincemaille [email protected] Argentina SMG LIFE Mr. Nicolas Passet [email protected] Partner Brazil MAPFRE Vida S.A. Ms. Débora Nunes Santos [email protected] Partner Canada Manulife Financial Corporation Mr. Kajan Ramanathan [email protected] Partner Chile MAPFRE Chile Ms. Nathalie Gonzalez [email protected] Partner Colombia MAPFRE Colombia Ms. Ingrid Olarte Pérez [email protected] Partner Costa Rica MAPFRE Costa Rica Mr. Armando Sevilla [email protected] Partner Dominican Republic (Life) MAPFRE BHD Mrs. Alejandra Quirico [email protected] Partner Dominican Republic (Health) MAPFRE Salud ARS, S. A. Mr. Christian Wazar [email protected] Partner Ecuador MAPFRE Atlas * Mr. Carlos Zambrano [email protected] Correspondent El Salvador MAPFRE Seguros El Salvador S.A. Mr. Daniel Acosta González [email protected] Partner French Guiana Refer to France - - Partner Guadeloupe Refer to France - - Partner Guatemala MAPFRE Guatemala Mr. Luis Pedro Chavarría [email protected] Partner Honduras MAPFRE Honduras Mr. Carlos Ordoñez [email protected] Partner Martinique Refer to France - - Partner Mexico Seguros Monterrey New York Life Ms. Paola De Uriarte [email protected] Partner Nicaragua MAPFRE Nicaragua Mr. Dany Lanuza Flores [email protected] Partner Panama MAPFRE Panama Mr. Manuel Rodriguez [email protected] Partner Paraguay MAPFRE Paraguay Mr. Sergio Alvarenga [email protected] Partner Peru MAPFRE Peru Mr. Ramón Acuña Huerta [email protected] Partner Saint Martin Refer to France - - Partner Saint Barthélemy Refer to France - - Partner Saint Pierre & Miquelon Refer to France - - Partner United States Prudential Insurance Company of America Mr. -
DSM's Integrated Annual Report 2015
Royal DSM Integrated Annual Report 2015 WorldReginfo - c41a4efa-17eb-497c-8f68-03022dabfb88 WorldReginfo - c41a4efa-17eb-497c-8f68-03022dabfb88 DSM at a glance Nutrition DSM Resins & Functional Materials is a global player in developing, manufacturing and marketing high-quality resins The Nutrition cluster comprises DSM Nutritional Products and solutions for paints, industrial coatings and fiber-optic coatings. DSM Food Specialties.These businesses serve the global Continuous innovation means that customers can meet industries for animal feed, food and beverage, pharmaceutical, regulatory needs and respond better to consumer demands for infant nutrition, dietary supplements and personal care. more sustainable materials. DSM Nutritional Products is one of the world’s leading Innovation Center producers of essential nutrients such as vitamins, carotenoids, nutritional lipids and other ingredients to the feed, food, DSM Innovation Center serves as an enabler and accelerator pharmaceutical and personal care industries. Among its of innovation within DSM as well as providing support to the customers are the world’s largest food and beverage clusters. With its Emerging Business Areas, the Business companies. DSM is uniquely positioned thanks to the Incubator and DSM Venturing & Licensing, the DSM Innovation combination of its broad portfolio of active ingredients, maximum Center has a general business development role, focusing on differentiation through formulation, local presence, a global areas outside the current scope of the business groups. premix network, and a strong focus on innovation. DSM Nutritional Products consists of the following business units: DSM’s Emerging Business Areas provide strong long-term growth platforms based on the company’s core competences Animal Nutrition & Health addresses the nutritional additives in life sciences and materials sciences. -
Final Terms for Certificates Final Terms
FINAL TERMS FOR CERTIFICATES FINAL TERMS DATED 15 JUNE 2020 BNP Paribas Issuance B.V. (incorporated in The Netherlands) (as Issuer) Legal entity identifier (LEI): 7245009UXRIGIRYOBR48 BNP Paribas (incorporated in France) (as Guarantor) Legal entity identifier (LEI): R0MUWSFPU8MPRO8K5P83 Up to 8,000 EUR “4Y Phoenix Snowball” Certificates relating to Assicurazioni Generali SpA Shares due 8 July 2024 ISIN Code: NL0015034828 under the Note, Warrant and Certificate Programme of BNP Paribas Issuance B.V., BNP Paribas and BNP Paribas Fortis Funding The Base Prospectus received visa no. 20-233 on 2 June 2020 BNP Paribas Arbitrage S.N.C. (as Manager) The Certificates are offered to the public in the Republic of Italy from 15 June 2020 to 26 June 2020 Any person making or intending to make an offer of the Securities may only do so: (i) in those Non-exempt Offer Jurisdictions mentioned in Paragraph 47 of Part A below, provided such person is a Manager or an Authorised Offeror (as such term is defined in the Base Prospectus) and that the offer is made during the Offer Period specified in that paragraph and that any conditions relevant to the use of the Base Prospectus are complied with; or (ii) otherwise in circumstances in which no obligation arises for the Issuer or any Manager to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or to supplement a prospectus pursuant to Article 23 of the Prospectus Regulation, in each case, in relation to such offer. None of the Issuer, the Guarantor or any Manager has authorised, nor do they authorise, the making of any offer of Securities in any other circumstances. -
Wilmington Funds Holdings Template DRAFT
Wilmington Global Alpha Equities Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS USD/CAD FWD 20210616 00050 3.16% DREYFUS GOVT CASH MGMT-I 2.91% MORGAN STANLEY FUTURE USD SECURED - TOTAL EQUITY 2.81% USD/EUR FWD 20210616 00050 1.69% MICROSOFT CORP 1.62% USD/GBP FWD 20210616 49 1.40% USD/JPY FWD 20210616 00050 1.34% APPLE INC 1.25% AMAZON.COM INC 1.20% ALPHABET INC 1.03% CANADIAN NATIONAL RAILWAY CO 0.99% AIA GROUP LTD 0.98% NOVARTIS AG 0.98% TENCENT HOLDINGS LTD 0.91% INTACT FINANCIAL CORP 0.91% CHARLES SCHWAB CORP/THE 0.91% FACEBOOK INC 0.84% FORTIVE CORP 0.81% BRENNTAG SE 0.77% COPART INC 0.75% CONSTELLATION SOFTWARE INC/CANADA 0.70% UNITEDHEALTH GROUP INC 0.70% AXA SA 0.63% FIDELITY NATIONAL INFORMATION SERVICES INC 0.63% BERKSHIRE HATHAWAY INC 0.62% PFIZER INC 0.62% TOTAL SE 0.61% MEDICAL PROPERTIES TRUST INC 0.61% VINCI SA 0.60% COMPASS GROUP PLC 0.60% KDDI CORP 0.60% BAE SYSTEMS PLC 0.57% MOTOROLA SOLUTIONS INC 0.57% NATIONAL GRID PLC 0.56% PUBLIC STORAGE 0.56% NVR INC 0.53% AMERICAN TOWER CORP 0.53% MEDTRONIC PLC 0.51% PROGRESSIVE CORP/THE 0.50% DANAHER CORP 0.50% MARKEL CORP 0.49% JOHNSON & JOHNSON 0.48% BUREAU VERITAS SA 0.48% NESTLE SA 0.47% MARSH & MCLENNAN COS INC 0.46% ALIBABA GROUP HOLDING LTD 0.45% LOCKHEED MARTIN CORP 0.45% ALPHABET INC 0.44% MERCK & CO INC 0.43% CINTAS CORP 0.42% EXPEDITORS INTERNATIONAL OF WASHINGTON INC 0.41% MCDONALD'S CORP 0.41% RIO TINTO PLC 0.41% IDEX CORP 0.40% DIAGEO PLC 0.40% LENNOX INTERNATIONAL INC 0.40% PNC FINANCIAL SERVICES GROUP INC/THE 0.40% ACCENTURE -
Part VII Transfers Pursuant to the UK Financial Services and Markets Act 2000
PART VII TRANSFERS EFFECTED PURSUANT TO THE UK FINANCIAL SERVICES AND MARKETS ACT 2000 www.sidley.com/partvii Sidley Austin LLP, London is able to provide legal advice in relation to insurance business transfer schemes under Part VII of the UK Financial Services and Markets Act 2000 (“FSMA”). This service extends to advising upon the applicability of FSMA to particular transfers (including transfers involving insurance business domiciled outside the UK), advising parties to transfers as well as those affected by them including reinsurers, liaising with the FSA and policyholders, and obtaining sanction of the transfer in the English High Court. For more information on Part VII transfers, please contact: Martin Membery at [email protected] or telephone + 44 (0) 20 7360 3614. If you would like details of a Part VII transfer added to this website, please email Martin Membery at the address above. Disclaimer for Part VII Transfers Web Page The information contained in the following tables contained in this webpage (the “Information”) has been collated by Sidley Austin LLP, London (together with Sidley Austin LLP, the “Firm”) using publicly-available sources. The Information is not intended to be, and does not constitute, legal advice. The posting of the Information onto the Firm's website is not intended by the Firm as an offer to provide legal advice or any other services to any person accessing the Firm's website; nor does it constitute an offer by the Firm to enter into any contractual relationship. The accessing of the Information by any person will not give rise to any lawyer-client relationship, or any contractual relationship, between that person and the Firm. -
Royal DSM N.V. Annual Report 2006
Royal DSM N.V. Annual Report 2006 Brighter Wider Better Together DSM Profile DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company develops, produces and sells innovative products and services that help improve the quality of life. DSM’s products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics (E&E). DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. The key drivers of this strategy are market-driven growth and innovation plus an increased presence in emerging economies. The group has annual sales of over €8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa, Australia and the Americas. More information about DSM can be found at www.dsm.com. Annual Report 2005 www.dsm.com DSM at a glance DSM’s activities have been grouped into business groups representing coherent product / market combinations. The business group directors report directly to the Managing Board. Nutrition Pharma €2,407m €916m DSM Nutritional Products DSM Pharmaceutical Products DSM Nutritional Products is the world’s largest supplier of nutri- DSM Pharmaceutical Products is one of the world’s leading tional ingredients, such as vitamins, carotenoids (anti-oxidants providers of high quality global custom manufacturing services and pigments), other biochemicals and fine chemicals, and to the pharmaceutical, biotech and agrochemical industries. -
Q1 2020 Building Sustainable Shareholder Value Business Overview
Q1 2020 Building Sustainable Shareholder Value Business overview Update in light of COVID-19 Business group results & highlights Capital management Asset portfolio Sustainability 2 A $26.51 billion leading global financial services organization Offices in 40,600 Employees 125,900 advisors 27 markets 2 2 2 Operating through a balanced and diversified model and focused on creating shareholder value now and in the future SUN LIFE • Q1 2020 1 Market capitalization in C$ as at March 31, 2020 3 2 As at December 31, 2019. Includes Asia joint ventures The Sun Life story • A diversified business model, with four strong pillars that can each compete, win and grow in their respective sectors and which leverage each other • Bound together by a strong balance sheet and risk culture, including no U.S. Variable Annuity or U.S. Long-Term Care • Digital transformation that is deeply embedded throughout the organization • Building on momentum created by past organic investments and acquisitions that will help drive earnings growth SUN LIFE • Q1 2020 4 Executing on our ambition to be one of the best insurance and asset management companies globally A Leader in Insurance and A Leader in U.S. Wealth Solutions in our CAN US Group Benefits Canadian Home Market A Leader in Asia A Leader in Global AM ASIA through Distribution Asset Management Excellence in Higher Growth Markets Each pillar Top quartile Disproportionate Top quartile total viewed as a Client share of top shareholder leader experience talent return SUN LIFE • Q1 2020 5 Consistently delivering value to shareholders 5-year total shareholder return1 Progress on medium-term objectives March 31, 2020 Sun Life 6.9% Medium-term objective Q1 2020 TSX 0.9% Underlying ROE2 12-14% 14.2% Canadian lifecos 0.0% Underlying EPS growth2 9% Global lifecos (1.2)% 8-10% Dividend payout ratio2 U.S. -
Demystifying Negative Screens: the Full Implications of ESG Exclusions
Marketing material for professional investors or advisers only Demystifying negative screens: The full implications of ESG exclusions December 2017 Contents Demystifying negative screens: Appendix: A close look at the full implications of ESG different screening options exclusions 14 Alcohol 3 Executive summary 15 Fossil fuels 3 Screening remains very popular 16 Fur in general 17 Gambling 4 But some individual screens are more 18 Nuclear popular than others 19 Pornography 4 Our Global Investor Survey highlights 20 Sin changing attitudes towards 21 Tobacco negative screens 22 Weapons 5 Interest in fossil fuel and tobacco divestment is rising 7 Focusing narrowly on returns can be deeply misleading 9 Screens can have a heavy impact on specific investment strategies 11 Details matter when implementing screens 11 Screen definition decisions can significantly alter exclusion lists and investment results 12 Different data providers can produce very different exclusion lists 12 Active management can add more value than passive when applying screens Demystifying negative screens: the full implications of ESG exclusions Screening out investments that Alexander Monk Sustainable do not meet environmental, social Investment Analyst or governance (ESG) criteria is and the Sustainable superficially simple but fraught with Investment Team practical challenges. Understanding the complexities and biases screens create before they are implemented and appropriately assessing performance afterward is crucial for investors. In this paper, we investigate the pitfalls when implementing different screens. Executive summary The chart in Figure 1 shows the extent to which typical Negative screens that sieve investments on environmental, negative exclusions constrain managers. Implementing social and governance grounds remain critical to many screens may be mechanical, but assessing their impact on investors. -
Demutualization Details
Demutualization Details 1. American Mutual Life – AmerUs- Indianapolis Life Insurance Company - Central Life Assurance - Central Life Assurance merged with American Mutual in 1994. American Mutual Life was renamed AmerUs Life Insurance Company in 1995. On September 20, 2000, it demutualized to become AmerUs Group. In 2001, the company merged with Indianapolis Life, which had also undergone a demutualization. Approximately 300,000 policyholders and heirs became entitled to receive $452 million in AmerUs Group common stock and $340 million in cash and policy credits. Distribution began on July 31, 2001. Eligible policyholders received a fixed component of 20 AmerUS common shares, as well as a variable component based on policy value. Those who elected to receive cash were compensate $26 per share entitlement. In the first year after the initial public offering, the price of an AmerUS common share increased 99%. The current value of AmerUS Group stock is approximately $45 per share. 2. Anthem Insurance - On July 31, 2002 Anthem Insurance Companies, Inc. completed its conversion from a mutual insurance company to a stock company, and became a wholly owned subsidiary of Anthem, Inc. Eligible policyholders and heirs became entitled to approximately 48 million shares of Anthem, Inc. common stock and cash totaling $2.06 billion. Compensation consisted of a fixed component of 21 Anthem common shares, as well as a variable component based on policy value. The shares were offered to the public at $36. In the first year after the initial public offering, the price of an Anthem common share increased 54%. 3. Equitable Life – Axa - In 1992 the Equitable Life Assurance Society of the United States demutualized and a new parent holding company, the Equitable Companies, was listed on the New York Stock Exchange. -
Insurance Market Report 2019 Foreword
Insurance market report 2019 Foreword 2 This report provides an overview of the Swiss sets as well as amounts due from derivative financial insurance market in 2019. The first part contains instruments no longer form part of the investments, information about the market as a whole. Parts 2, 3 some of the key figures published in the insurance Foreword Foreword and 4 provide detailed information on the life, non- market report 2018 such as the total assets, the in- life and reinsurance sectors. vestments, the underwriting liabilities, the gains on investments, the return on investments and the in- The figures presented in the report have been pre- formation on asset allocation differ from the previous pared on a statutory basis; any changes in the values year’s figures provided in this report. of assets and liabilities generally do not correspond FINMA | Insurance market report 2019 FINMA | Insurance market report to market value adjustments. For example, bonds are As announced in last year’s report, since the 2019 shown at amortised cost, which means the carrying annual survey, this report includes information on the values are not sensitive to interest rates. On the li- group life reporting for occupational pension schemes abilities side, technical provisions for life insurers are of life insurance companies for the first time and discounted with technical interest rates and not with replaces the transparency report on occupational the prevailing market yield curve. Technical provisions pensions. The information on the group life reporting for non-life insurers are generally undiscounted, while for occupational pension schemes of life insurance accident insurance benefits (UVG) have been companies can be found in ”Life insurance com- specifically excluded. -
Assicurazioni Generali
Assicurazioni Generali REPORTS AND PROPOSALS ON THE ITEMS OF THE AGENDA Ordinary shareholders’ meeting 26-28-30 April 2011 th year9 2010 REPORTS AND PROPOSALS ON THE ITEMS OF THE AGENDA Ordinary shareholders’ meeting 26-28-30 April 2011 2010 ECPI Ethical Index Euro ECPI Ethical Index Global FTSE ECPI Italia SRI: Leaders Index; Benchmarck Index Registered Office and Central Head Office in Trieste Head Office for Italian Operations in Mogliano Veneto Capital (fully paid in) Euro 1,556,873,283.00 Fiscal code and Trieste Companies Register 00079760328 Company entered in the Register of Italian Insurance and Reinsurance Companies under no. 100003 Parent Company of Generali Group, entered in the Register of Insurance Groups under no. 026 CHAIRMAN Cesare Geronzi VICE - CHAIRMEN Vincent Bolloré, Francesco Gaetano Caltagirone, Alberto Nicola Nagel MANAGING DIRECTOR AND GROUP CEO Giovanni Perissinotto (*) (*) He acts also as General Manager MANAGING DIRECTOR Sergio Balbinot (*) DIRECTORS Ana Patricia Botin / Cesare Calari / Carlo Carraro (**) Directors who, together with the Chairman, Diego Della Valle / Petr Kellner / Angelo Miglietta (**) Vice-Chairmen and Managing Directors, form the Executive Committee Alessandro Pedersoli / Lorenzo Pellicioli (**) / Reinfried Pohl Paola Sapienza / Paolo Scaroni / Francesco Saverio Vinci GENERAL COUNCIL Giorgio Davide Adler / José Ramón Álvarez Rendueles José Maria Amusátegui de la Cierva / Francesco Maria Attaguile Claude Bébéar / Kenneth J. Bialkin / Gerardo Broggini Giacomo Costa / Maurizio De Tilla / Enrico -
2011 Annual Report
2011 Annual Report The Lazard model is simple and powerful. Our model is built on Financial In Asset Management, we are Advisory and Asset Management— a world-class firm with strong what we consider the two most performance and growth. We are attractive businesses in financial leaders in emerging markets and services. global equities. We provide clients with global and local investment We compete on equal footing with solutions that we export and import firms many times our size, without around the world. the inherent risks and conflicts that come with the use of capital. We aim to drive shareholder returns through quality revenue growth, In Financial Advisory, we are investing smartly in hiring and long-standing leaders in M&A and expansion, focusing on realizing strategic advice. We offer clients operating leverage, and returning extraordinary depth and experience cash to shareholders. in our understanding of capital structure and capital markets. We are leaders in restructuring and in advising governments around the world. And our Capital Structure Advisory business is a powerful complement to our strategic advice. Financial Highlights ($mm, except per share data) 2011 2010 2009 Net Revenue $1,830 $1,905 $1,531 Operating Revenue1,3 1,884 1,979 1,618 Adjusted Net Income2,3 179 281 11 Adjusted Net Income Per Share—Diluted2,3 $1.31 $2.06 $0.09 OPERATING REVENUE1,3 ($mm) 2011 NET REVENUE BY BUSINESS4 2,500 Financial Asset Advisory Management $2,015 $1,979 2,000 $1,884 $1,675 $1,618 53% 47% 1,500 2011 NET REVENUE BY GEOGRAPHY 1,000 59% 33% United Europe States 500 8% Rest of World 0 2007 2008 2009 2010 2011 STOCK PERFORMANCE5 Lazard Ltd S&P Financial Index S&P 500 Index $200 150 100 50 0 30 Dec 2005 29 Dec 2006 31 Dec 2007 31 Dec 2008 31 Dec 2009 31 Dec 2010 30 Dec 2011 1 Excludes revenues related to non-controlling interests, interest expense 3 A non-U.S.